Grzegorz Kreiner, PhD
Assistant professor at Institute of Pharmacology PAS, Dept. Brain Biochemistry. Principal Investigator on two research grants funded by National Science Center (NCN):
Opus7 2014/13/B/NZ7/02293: Evaluation of the role of transcription factor CREB in the mechanism of antidepressant treatment: study on the novel genetic models based on the Cre/loxP system (2015-2018)
Opus13 2017/25/B/NZ7/02406: Evaluation of the influence of progressive noradrenergic neurodegeneration on dopaminergic system functioning in context of presymptomatic phase of Parkinson's disease (2018-2021)
-
Selective Depletion of CREB in Serotonergic Neurons Affects the Upregulation of Brain-Derived Neurotrophic Factor Evoked by Chronic Fluoxetine Treatment.
Katarzyna Rafa-Zabłocka, Grzegorz Kreiner, Monika Bagińska, Irena Nalepa
Frontiers in neuroscience, 10.3389/fnins.2018.00637
PMID:30294251 -
What have we learned recently from transgenic mouse models about neurodegeneration? The most promising discoveries of this millennium.
Grzegorz Kreiner
Pharmacological reports : PR, S1734-1140(17)30841-1 10.1016/j.pharep.2018.09.006
PMID:30312896 -
Transgenic mice lacking CREB and CREM in noradrenergic and serotonergic neurons respond differently to common antidepressants on tail suspension test.
Katarzyna Rafa-Zabłocka, Grzegorz Kreiner, Monika Bagińska, Justyna Kuśmierczyk, Rosanna Parlato, Irena Nalepa
Scientific reports, 10.1038/s41598-017-14069-6
PMID:29044198 -
Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target - Evidence from a mouse diabetic neuropathy model.
Magdalena Zychowska, Ewelina Rojewska, Anna Piotrowska, Grzegorz Kreiner, Irena Nalepa, Joanna Mika
International immunopharmacology, S1567-5769(17)30360-0 10.1016/j.intimp.2017.09.021
PMID:28961489 -
Lack of riluzole efficacy in the progression of the neurodegenerative phenotype in a new conditional mouse model of striatal degeneration.
Grzegorz Kreiner, Katarzyna Rafa-Zabłocka, Piotr Chmielarz, Monika Bagińska, Irena Nalepa
PeerJ, 10.7717/peerj.3240
PMID:28462043
-
Evaluation of the influence of progressive noradrenergic neurodegeneration on dopaminergic system functioning in context of presymptomatic phase of Parkinson's disease. - 2018-01-03 - 2021-01-02
OPUS13 2017/25/B/NZ7/02406
Principal Investigator: Dr Grzegorz Kreiner -
Evaluation of the role of transcription factor CREB in the mechanisms antidepressant treatment - 2015-01-27 - 2018-11-26
OPUS7 2014/13/B/NZ7/02293
Principal Investigator: Dr Grzegorz Kreiner -
Pharmacological evaluation of possible neuroprotective strategies in novel genetic mouse models of progressive neurodegeneration, based on tissue specific inducible Cre/loxP system - 2012-08-22 - 2016-04-21
OPUS2 2011/03/B/NZ7/05949
Principal Investigator: Dr Grzegorz Kreiner
-
Investigation of noradrenergic and glucocorticoid system interactions in GRDBHCre mice and their evaluation as a potential model of depression - 2010-02-01 - 2014-12-31
POIG 01.01.02-12-004/09 DeMeTer (Depression – Mechanisms – Therapy).
Task 1.1 Subtask 1.1.2. Main topic: Modelling of depression – strategy of learning about its aetiology. Principal Investigator of task 1.2: Dr Grzegorz Kreiner
National
International
- Dr Andrii Domanskyi, Institute of Biotechnology, University of Helsinki, Finland
- Dr Rosanna Parlato, Institute of Applied Physiology, University of Ulm, Germany
